Emiliano Roselli

Cordoba, X, Argentina

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

CAR T cell-driven induction of iNOS in tumor-associated macrophages promotes CAR T cell resistance in B cell lymphoma.

CAR T cell-driven induction of iNOS in tumor-associated macrophages promotes CAR T cell resistance in B cell lymphoma.

Journal: Research square
Published: April 16, 2025

γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer.

γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer.

Journal: Science advances
Published: May 03, 2023

4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells.

4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells.

Journal: Journal for immunotherapy of cancer
Published: September 30, 2021

Correction to: High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer.

Correction to: High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer.

Journal: Breast cancer research : BCR
Published: April 23, 2021

High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer.

High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer.

Journal: Breast cancer research : BCR
Published: January 25, 2021

Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes.

Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes.

Journal: The Journal of clinical investigation
Published: January 19, 2021

Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity.

Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 09, 2019

CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms.

CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: September 26, 2019

Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation.

Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation.

Journal: Frontiers in immunology
Published: July 14, 2019

TLR3 Activation of Intratumoral CD103+ Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity.

TLR3 Activation of Intratumoral CD103+ Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity.

Journal: Frontiers in immunology
Published: December 18, 2018

Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma.

Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma.

Journal: PloS one
Published: September 15, 2016

Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 Ligand.

Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 Ligand.

Journal: PloS one
Published: July 21, 2015
Showing 1-12 of 13

Last Updated: 09/26/2026